Trial Profile
A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Vorinostat (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Biomarker